His research delves into the commercialization of new technologies in entrepreneurial ventures, with a keen emphasis on the strategic implications of artificial intelligence (AI). In his work, AI not only stands as a key area of study but also paves the way for methodological innovations. Utilizing advanced machine learning methods and big data, he probes strategic questions of technology commercialization. His insights have been showcased in esteemed publications like the Harvard Business Review, Journal of Professions and Organizations, and Health and Place.  

Beyond academia, he actively influences the tech landscape by serving on boards and advisory panels for VC-funded startups globally. Amid the COVID-19 pandemic, his leadership as the director of the Oxford COVID-19 Impact Monitor shaped the policies at 10 Downing Street and the National Health Service. He is an alumnus and former faculty member of the University of Oxford. 

With Matthias Qian, ESMT has 46 faculty members from 19 countries.